Systemic inflammation and risk of Parkinson's disease: A prospective cohort study and genetic analysis
CONCLUSIONS: Systemic inflammation at baseline measured by CRP level is associated with decreased future risk of PD. These discoveries contribute to a deeper comprehension of the role of inflammation in the risk of PD, and hold implications for the design of therapeutic interventions in clinical trials.PMID:38336023 | DOI:10.1016/j.bbi.2024.02.013
Source: Brain, Behavior, and Immunity - Category: Neurology Authors: Chunyu Li Bin Ke Jianhai Chen Yi Xiao Shichan Wang Rirui Jiang Xiaoting Zheng Junyu Lin Jingxuan Huang Huifang Shang Source Type: research
More News: Brain | Clinical Trials | Genetics | Neurology | Parkinson's Disease | Statistics | Study